Successful treatment of acute portal vein thrombosis with rivaroxaban.

  title={Successful treatment of acute portal vein thrombosis with rivaroxaban.},
  author={Sven Pannach and Jana Babatz and Jan Beyer-Westendorf},
  journal={Thrombosis and haemostasis},
  volume={110 4},
doi:10.1160/TH13-05-0407 Thromb Haemost 2013; 110: 626–627 Splanchnic vein thrombosis (SVT) is a potentially life-threatening disease (1) and anticoagulant therapy with low-molecularweight heparin or vitamin K antagonists is recommended (2). However, these agents lack evidence from randomised prospective trials, are not specifically approved and have significant limitations (2, 3). Modern oral anticoagulants such as rivaroxaban may offer pharmacologic and logistic benefits (3, 4). Our T&H Image… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
10 Citations
6 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…